Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Huizhi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7692-2106; OpenAlex author ID A5102005196. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: 3 papers · 2021: none · 2022: 2 papers · 2023: 3 papers · 2024: 1 paper

Papers 10

  1. TTC22 as a potential prognostic marker and therapeutic target in pancreatic cancer: Insights into immune infiltration and epithelial‑mesenchymal transition. First author DOI 10.3892/ol.2023.14143↗
  2. LncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway. Co-author DOI 10.1016/j.abb.2023.109783↗
  3. LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway. Co-author DOI 10.1080/15384101.2023.2216507↗
  4. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR. Co-author DOI 10.1155/2023/3914687↗
  5. The Role of Adipokines in Pancreatic Cancer. First author DOI 10.3389/fonc.2022.926230↗
  6. Pancreatic Cancer Cell-Derived Exosomes Promote Lymphangiogenesis by Downregulating ABHD11-AS1 Expression. Co-author DOI 10.3390/cancers14194612↗
  7. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells. First author DOI 10.1002/jcb.29308↗
  8. Methyl-CpG-binding domain 3 inhibits stemness of pancreatic cancer cells via Hippo signaling. Co-author DOI 10.1016/j.yexcr.2020.112091↗
  9. Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial-mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1038/s41389-020-00258-y↗
  10. The UCA1/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth. Co-author PMID 30949406↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Xu · 8 shared papers, 2019–2023 · strength 1.17
  2. Yuntao Ding · 5 shared papers, 2022–2024 · strength 1.04
  3. Aihua Gong · 6 shared papers, 2019–2023 · strength 0.81
  4. Qi Wang · 3 shared papers, 2022–2023 · strength 0.61
  5. Min Xu · 1 shared paper, 2024 · strength 0.23
  6. Wei Chen · 2 shared papers, 2020 · strength 0.20
  7. Min Xu · 1 shared paper, 2022 · strength 0.20
  8. Youli Zhang · 2 shared papers, 2019–2020 · strength 0.19
  9. Yawen Liu · 2 shared papers, 2019–2020 · strength 0.19
  10. Xulin Zhou · 1 shared paper, 2022 · strength 0.16
  11. Sihui Wu · 1 shared paper, 2022 · strength 0.16
  12. Jingyu Min · 1 shared paper, 2020 · strength 0.10
  13. Wan‐Xin Peng · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.